PA-Clinical Pathology

Medicine & Life Sciences

1. Coronavirus 100%
2. Acute Myeloid Leukemia 76%
3. SARS Virus 74%
4. Plasma Exchange 67%
5. prothrombin complex concentrates 49%
6. High-Throughput Nucleotide Sequencing 48%
7. Severe Acute Respiratory Syndrome 47%
8. Bone Marrow 44%
9. Metagenomics 43%
10. Fluorescence In Situ Hybridization 39%
11. Clinical Decision Support Systems 38%
12. Precursor Cell Lymphoblastic Leukemia-Lymphoma 37%
13. Electronic Health Records 35%
14. Leukocyte Immunoglobulin-like Receptor B1 32%
15. Microcystic adnexal carcinoma 30%
16. Gene Fusion 30%
17. Infections 28%
18. Cytogenetics 28%
19. Streptococcus equi 27%
20. B-Lymphocytes 26%
21. Tarsal Bones 26%
22. Medical Order Entry Systems 26%
23. Pyuria 25%
24. Microbiology 24%
25. Communicable Diseases 24%
26. Meningitis 23%
27. Reptiles 23%
28. Pandemics 23%
29. Thrombotic Thrombocytopenic Purpura 23%
30. Lenalidomide 23%
31. Nucleocapsid 23%
32. Antimicrobial Stewardship 23%
33. Sensitivity and Specificity 22%
34. Menorrhagia 22%
35. Brain Abscess 22%
36. Failure to Thrive 22%
37. Primary Myelofibrosis 21%
38. Decision Trees 21%
39. Blood Component Removal 21%
40. Pediatrics 21%
41. Ewing's Sarcoma 21%
42. Soft Tissue Infections 21%
43. Juvenile Arthritis 20%
44. Rhabdomyosarcoma 20%
45. Information Technology 20%
46. Gene Targeting 20%
47. Vaccines 20%
48. Myasthenia Gravis 20%
49. Therapeutics 20%
50. Neoplasms 20%
51. Basal Cell Carcinoma 19%
52. Intracranial Hemorrhages 19%
53. Datasets 19%
54. Rituximab 18%
55. Osteomyelitis 18%
56. Immunocompromised Host 18%
57. Warfarin 18%
58. Reverse Transcription 18%
59. Lymphadenopathy 17%
60. Penicillins 17%
61. Immunohistochemistry 17%
62. Lymphoma 17%
63. Immunoglobulins 17%
64. Chromosome Aberrations 16%
65. Emergencies 16%
66. Occupational Groups 16%
67. Urinary Tract Infections 16%
68. Transplant Recipients 16%
69. Autoantibodies 16%
70. Uncertainty 16%
71. Nivolumab 15%
72. LDL Cholesterol 15%
73. Vaccination 15%
74. Fungi 15%
75. Leukocytes 15%
76. Dendritic Cells 15%
77. Canidae 15%
78. Antiviral Agents 14%
79. Antibodies 14%
80. Transplants 14%
81. Proteins 14%
82. Hypersensitivity 14%
83. Delivery of Health Care 14%
84. Atherosclerosis 14%
85. Inpatients 13%
86. Chromosomes 13%
87. Catheters 13%
88. Mutation 13%
89. Flow Cytometry 13%
90. Hemorrhage 13%
91. Myocarditis 13%
92. Monocytes 12%
93. Biomarkers 12%
94. Routine Diagnostic Tests 12%
95. Cardiovascular Diseases 12%
96. Urine 12%
97. Polymerase Chain Reaction 12%
98. RNA 12%
99. Cohort Studies 11%
100. Retrospective Studies 11%